Search Results 421-430 of 15113 for albinism

  1. Mayo Clinic Minute: Benefits, dangers of fentanyl

    Mike Hooten, M.D. (Anethesiology, Mayo Clinic): It is many, many times more potent than morphine, oxycodone, oxycontin, Vicadin, dilaudid, hydromorphine, all ...

  2. The Olmsted NAFLD Epidemiology Study (TONES) - Mayo Clinic

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  3. Mayo Clinic

    Their crucial work saves lives every day. Let Mayo Clinic researchers know they're appreciated with a quick message.

  4. A Study to Investigate the Effects of GC4419 on Radiation-Induced Oral Mucositis in Patients With Head/Neck Cancer - Mayo Clinic

    The purpose of this study is to determine if GC4419, administered prior to intensity-modulated radiation therapy (IMRT), reduces the severity of radiation- ...

  5. A Registry for the Knowledge and Evaluation Research (KER) Unit - Mayo Clinic

    About this study. The purpose of this registry is to develop a database of patient experience that can be used for internal research, education, ...

  6. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

    The purpose of the study is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with ...

  7. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

    A leukapheresis procedure will be performed to manufacture bb2121 chimeric antigen receptor (CAR) modified T cells. Prior to bb2121 infusion subjects will ...

  8. Inhibiting HDAC6 and HDAC1 upregulates RhoB with divergent downstream targets, BIM

    Background: Anaplastic thyroid carcinoma (ATC) is a highly aggressive undifferentiated carcinoma with a mortality rate near 100%. This high.

  9. Patient Stories - Urshila Durani, M.D., M.P.H. - Mayo Clinic

    Search for a doctor. Urshila Durani, M.D., M.P.H.. Hematologist; Internist; Oncologist. Request an Appointment · Overview. Patient Stories.

  10. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

    About this study. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic ...